Template:Oroboros MitoFit box: Difference between revisions
From Bioblast
Laner Verena (talk | contribs) No edit summary |
Laner Verena (talk | contribs) No edit summary |
||
Line 8: | Line 8: | ||
* OROBOROS INSTRUMENTS participates in two HORIZON 2020 funded Marie Skłodowska-Curie projects: | * OROBOROS INSTRUMENTS participates in two HORIZON 2020 funded Marie Skłodowska-Curie projects: | ||
:* '''TRACT''' – '''Tra'''ining in '''C'''ancer mechanisms and '''T'''herapeutics: TRACT will enable eleven PhD Fellows to complete research projects in the three critical areas: biomarker discovery, molecular resistance mechanisms and metabolic transformation mechanisms. This will allow for the discovery of novel insights into the molecular and cellular basis of oral and oesophageal cancer and generate new diagnostic tools and therapeutics that will improve patient response and survival. '''[[TRACT|More info? | :* '''TRACT''' – '''Tra'''ining in '''C'''ancer mechanisms and '''T'''herapeutics: TRACT will enable eleven PhD Fellows to complete research projects in the three critical areas: biomarker discovery, molecular resistance mechanisms and metabolic transformation mechanisms. This will allow for the discovery of novel insights into the molecular and cellular basis of oral and oesophageal cancer and generate new diagnostic tools and therapeutics that will improve patient response and survival. '''[[TRACT|More info?]]''' | ||
:*'''TRANSMIT'''- Start in January 2017. '''[http://cordis.europa.eu/project/rcn/205395_en.html More info?]''' | :*'''TRANSMIT'''- Start in January 2017. '''[http://cordis.europa.eu/project/rcn/205395_en.html More info?]''' |
Revision as of 12:19, 12 January 2017
- OROBOROS INSTRUMENTS participates in two HORIZON 2020 funded Marie Skłodowska-Curie projects:
- TRACT – Training in Cancer mechanisms and Therapeutics: TRACT will enable eleven PhD Fellows to complete research projects in the three critical areas: biomarker discovery, molecular resistance mechanisms and metabolic transformation mechanisms. This will allow for the discovery of novel insights into the molecular and cellular basis of oral and oesophageal cancer and generate new diagnostic tools and therapeutics that will improve patient response and survival. More info?
- TRANSMIT- Start in January 2017. More info?
- Horizon 2020 COST Action CA15203 MITOEAGLE - official start 2016 Sep 12. More info?